- Meeting abstract
- Open Access
Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure
Critical Care volume 5, Article number: P082 (2001)
iNOS inhibition in AHF is controversial, fuelled by conflicting results from studies using varieties of pharmacological agents, animal models and temporal protocols.
We have previously described a robust model of acute hepatic and multi-organ failure in the Wistar rat. AHF was induced by two i.p. injections (500 mg/kg, 8 hours apart) of thioacetamide (TAA). Six groups were studied (n = 5). Group 1 received TAA alone. Groups 2, 3 & 4 followed protocol for Group 1, however, Groups 2 & 3 were pre-treated and Groups 4 & 5 post-TAA treated with iNOS inhibitors AMG (100 mg/kg s.c.) and L-NAME (100 mg/kg s.c.) for 5 days.
AMG is a more selective iNOS inhibitor, significantly reducing parameters of AHF compared L-NAME. Beneficial effects are, however, negated if iNOS inhibitors are administered after TAA, exacerbating hepatic injury, increasing mortality, and thus demonstrating temporal constraints.
About this article
Cite this article
Rahman, T., Hodgson, H. Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure. Crit Care 5, P082 (2001). https://doi.org/10.1186/cc1149
- Public Health
- Animal Model
- Beneficial Effect
- Emergency Medicine
- Pharmacological Agent